<DOC>
	<DOCNO>NCT02934802</DOCNO>
	<brief_summary>This post-market clinical follow-up study intend investigate survival rate 5 year e.motion® PS Pro System .</brief_summary>
	<brief_title>Non-Interventional Consecutive Prospective Study e.Motion® PS Pro Prosthesis Total Knee Artroplasty</brief_title>
	<detailed_description />
	<criteria>Patient sign informed consent Patients 18 Total Knee Prosthesis e.motion® PS Pro decide Patients willing participate 5 year followup Active suspect infection Tumor concern knee Patient vulnerable legal protection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>